Biotechnology - Sarasota, Florida, United States
Alzheimer's Institute of America (AIA) has pioneered leading research and licensing its researched technology in hopes of striving to discover and develop innovative therapeutic products for major unmet medical needs. Educating the world on the disease and conducting and promoting research for a cure. In addition to developing its own research, AIA has a joint venture with Archer Pharmaceuticals to produce and test its own pharmaceutical preparations for neuropsychiatric disorders. Archer is a Contract Research Organization (CRO) primarily focused on analyses of small molecule DS and final DP of small molecules.As a CRO, Archer provides the human clinical trial facility for AIA in its commit to providing its customers with quality GMP compliant services ranging from synthesis and manufacturing, to analytical method development and testing. Our experienced staff of Ph.D. chemists, QC professionals, and laboratory analysts use and adapt compendial and non-compendial methods, perform necessary change controls for evolving product lines, and generate de novo methods and specifications as required.With your help and support we are close to discovering a cure for Alzheimer's Disease.